Fresenius Medical Care Announces EUR 1 Billion Share Buyback Program

On June 17, 2025, Fresenius Medical Care AG unveiled a significant financial strategy: a share buyback program totaling EUR 1 billion. This operation will take place in tranches over the course of two years, starting in the second half of 2025. The shares will be predominantly redeemed, with a smaller portion allocated for incentive-based compensation plans.

The program leverages the authorization granted during the company's Annual General Meeting on May 20, 2021, to purchase and utilize treasury shares. Any continuation beyond the current authorization will require further resolutions from the company’s governing bodies.

The initiative signifies Fresenius Medical Care's strategic financial planning, potentially impacting stock value and market perception. The execution will occur on the stock exchange, underlining the company's active engagement in managing its capital structure.